Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases

Details for Australian Patent Application No. 2007254243 (hide)

Owner Ludwig Institute for Cancer Research

Inventors Eriksson, Ulf

Agent Davies Collison Cave

Pub. Number AU-A-2007254243

PCT Pub. Number WO2007/136679

Priority 60/801,549 17.05.06 US

Filing date 17 May 2007

Wipo publication date 29 November 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/136679 Priority application(s): WO2007/136679

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007254244-3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

2007254232-N-benzoyl-and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists